Results 121 to 130 of about 8,184 (177)

Assessment of scabies diagnosis and the impact of MDA for onchocerciasis on the burden of scabies in an endemic community in Ghana. [PDF]

open access: yesBMC Infect Dis
Osei-Mensah J   +10 more
europepmc   +1 more source

Significant gap between Point participation and long‑term treatment adherence: An evaluation of ivermectin MDA in the Kwanware‑Ottou persistent onchocerciasis transmission focus, Wenchi, Ghana. [PDF]

open access: yesPLoS Negl Trop Dis
Nditanchou R   +15 more
europepmc   +1 more source

The risk of onchocerciasis infection by human population movements between high and low transmission settings in Ghana. [PDF]

open access: yesPLoS Negl Trop Dis
Pi-Bansa S   +12 more
europepmc   +1 more source

Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review. [PDF]

open access: yesPLoS Negl Trop Dis
Lotola Mougeni F   +7 more
europepmc   +1 more source

ONCHOCERCIASIS

Infectious Disease Clinics of North America, 1992
Onchocerciasis is a parasitic disease with blinding consequences infecting approximately 18 million persons worldwide. In hyperendemic areas, nearly half the population are likely to become blind before they die. Blindness reduces the life expectancy of those affected and has an enormous socioeconomic impact on these communities. Ivermectin, given as a
A E, Malatt, H R, Taylor
openaire   +2 more sources

Onchocerciasis

International Ophthalmology, 1990
Onchocerciasis is a devastating blinding disease caused by the parasite Onchocerca volvulus that infects about 80 million people, causing blindness and visual impairment in 1-2 million people. In hyperendemic areas, more than half of the population will become blind from onchocerciasis before they die.
openaire   +4 more sources

Treatment of Onchocerciasis

Drugs, 1996
Onchocerciasis ('river blindness') has for several centuries been the scourge of people living in certain areas of the world where the disease is endemic. The treatment available up to 10 years ago, diethylcarbamazine, had very severe secondary effects.
Y, Van Laethem, C, Lopes
openaire   +2 more sources

Gynaecomastia in onchocerciasis

The Lancet, 1997
Many clinical manifestations of onchocerciasis have been described, but we have not seen any reports of gynaecomastia. We are involved in a field study looking at the impact of ivermectin on oncho-dermatitis in hyperendemic communities, and found gynaecomastia in 63 of 301 men examined before being given ivermectin (figure).
D O, Okello   +2 more
openaire   +2 more sources

Control of Onchocerciasis

2006
Onchocerciasis is a filarial infection which causes blindness and debilitating skin lesions. The disease occurs in 37 countries, of which 30 are found in Africa (the most affected in terms of the distribution and the severity of the clinical manifestations of the disease), six in the Americas and one in the Arabian Peninsula.
Boakye A, Boatin, Frank O, Richards
openaire   +2 more sources

Home - About - Disclaimer - Privacy